Ingredients and solutions for the food industry
Microorganisms and active ingredients for human health
Lactic acid bacteria for the agri-veterinary sector

CSL USA INC. opens new fermentation facility to produce food ingredients and cultures

22/06/2022

CSL USA INC. opens new fermentation facility to produce food ingredients and cultures, bacterial cultures, and probiotics for use in dairy, food, dietary supplements, pharma, and agriculture.


Franksville, Wisconsin, USA: Today, CSL USA INC. (Cultures Supporting Life), an independent entity, is born with the intention of offering new technology solutions to meet the growing needs of the US biotechnology market. CSL USA announces the opening of its new custom fermentation facility, located in Franksville, Wisconsin. The 80,000 sq. ft. facility will support the growing Food, Beverage, Health, and Nutrition markets.
CSL USA will have access to strains and technologies developed by Sacco System (Milan, Italy) over its 150 years of history.
Sacco System produces food ingredients including food cultures, bacterial cultures, and probiotics, for the dairy, food, dietary supplements, pharma, and agriculture markets since 1872. Sacco System is also one of the largest contract fermentation organizations in the world.


As an official technology partner to Sacco System, CSL USA enters the market with a strong platform of science and a long history of fermentation experience. CSL USA will promote the full line of food ingredients, food cultures, bacterial cultures, probiotics, and comprehensive fermentation services to customers in the US. This business association will provide mutual benefits to CSL USA and Sacco System, and most importantly, to our customers today and long into the future.

Kyle Griffiths, Vice President of Sales & Marketing for CSL USA said in a written statement, “The new CSL USA production facilities located in the United States will increase our flexibility to serve the needs of US customers, while increasing the global capacity for our worldwide customer base. We believe that the creation of CSL USA will accelerate our efforts to grow in both the health and nutrition and the food and beverage markets globally as we bring new products and service to the US marketplace”.

For Information contact info@cslusa.com

Latest News

19 March 2026
A regulatory achievement for Sacco System: our Heat-Inactivated CRL1505® receives GRAS status

An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.

24 January 2026
SYNBIO®: Sacco System’s probiotic support for healthy ageing

The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy

22 December 2025
Sacco System grows in Latin America: BioInsumos in Uruguay and Sacco Brasil acquired.

The Group is accelerating its South American growth strategy through a twofold transaction: the acquisition of a Uruguayan company and the full absorption of its Brazilian subsidiary. The Group is

11 December 2025
Sacco System Presents PerforMilk®: Unlocking Milk’s Full Potential by Preserving Protein Quality 

Milk is the most precious resource in dairy production. High-quality dairy products start with high-quality milk—and in today’s rapidly evolving dairy landscape, protecting that quality has never been more critical. 

20 November 2025
Unveiling the survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model

“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been

07 February 2025
L. rhamnosus CA15 Achieves GRAS Status: A Milestone for Women’s Health

GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a

08 January 2025
Sacco System Australia’s Heat-Inactivated Postbiotics Receive Positive Recommendations from FSANZ

Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1

25 November 2024
News
Our 2023 sustainability report is online!

We are proud to present the fifth edition of our Sustainability Report, an opportunity to reflect on the milestones achieved and the challenges ahead…

16 April 2024
News
Sacco System is pleased to announce the grand opening of its development site in Australia.

Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland…

26 March 2024
News
Sacco System companies have been awarded as Sustainability champions by Ecovadis

At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici…

18 March 2024
News
List Biotherapeutics and Sacco System Announce Lead Share Agreement

List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement…

26 February 2024
News
CSL FRANCE becomes SACCO SYSTEM FRANCE

Sacco System is the international biotechnological company dedicated to the food, nutraceutical, and pharmaceutical industries…